INTELLIGENT BIO SOLUTIONS INC. (INBS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 1.5M 3M 4.5M Q1 '21: 122.1K Q2 '21: 405.9K Q3 '21: 441.8K Q4 '21: 2M Q1 '23: 748.5K Q2 '23: 927.4K Q3 '23: 1.2M Q4 '23: 1.6M Q1 '24: 2.1M Q2 '24: 2.5M Q3 '24: 2.8M Q4 '24: 3.1M Q1 '25: 3.2M Q2 '25: 3M Q3 '25: 2.9M Q4 '25: 3.1M Q1 '26: 3.3M Q2 '26: 3.6M Q3 '26: 3.9M Q4 '26: 4.2M Q2 '21 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Gross Profit TTM

0 700K 1.4M 2.1M Q1 '24: 559K Q2 '24: 514.2K Q3 '24: 659.6K Q4 '24: 1.4M Q1 '25: 1.5M Q2 '25: 1.6M Q3 '25: 1.7M Q4 '25: 1.2M Q1 '26: 1.4M Q2 '26: 1.7M Q3 '26: 1.8M Q4 '26: 2M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q1 '22: -6.3M Q2 '22: -8.9M Q3 '22: -7.1M Q4 '22: -8.3M Q1 '23: -8.1M Q2 '23: -6.8M Q3 '23: -12M Q4 '23: -12.6M Q1 '24: -13.9M Q2 '24: -13.8M Q3 '24: -10.2M Q4 '24: -10.3M Q1 '25: -10.5M Q2 '25: -10.8M Q3 '25: -10.4M Q4 '25: -10.7M Q1 '26: -10.9M Q2 '26: -11.3M Q3 '26: -11.7M Q4 '26: -12.6M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Net Income TTM

-15M -10M -5M 0 5M 10M 15M Q1 '22: -7.4M Q2 '22: -8.9M Q3 '22: -7.1M Q4 '22: -8.3M Q1 '23: -8.1M Q2 '23: -5M Q3 '23: -10.1M Q4 '23: -10.6M Q1 '24: -11.8M Q2 '24: -13.4M Q3 '24: -10M Q4 '24: -10.2M Q1 '25: -10.4M Q2 '25: -10.7M Q3 '25: -10.3M Q4 '25: -10.6M Q1 '26: -10.9M Q2 '26: -11.3M Q3 '26: -11.6M Q4 '26: -12.4M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Cost of Revenue TTM

0 800K 1.6M 2.4M Q1 '24: 1.5M Q2 '24: 1.9M Q3 '24: 2.2M Q4 '24: 1.7M Q1 '25: 1.6M Q2 '25: 1.5M Q3 '25: 1.2M Q4 '25: 1.8M Q1 '26: 1.9M Q2 '26: 1.9M Q3 '26: 2.1M Q4 '26: 2.2M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26

Operating Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q1 '22: -8.5M Q2 '22: -9.2M Q3 '22: -3.3M Q4 '22: -3.4M Q1 '23: -5.3M Q2 '23: -6.3M Q3 '23: -8.5M Q4 '23: -7.4M Q1 '24: -6.8M Q2 '24: -7.3M Q3 '24: -7.2M Q4 '24: -9.6M Q1 '25: -10.6M Q2 '25: -10.1M Q3 '25: -10.4M Q4 '25: -9.7M Q1 '26: -10.1M Q2 '26: -9.4M Q3 '26: -11M Q4 '26: -11.9M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Free Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q4 '26: -12.1M Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q3 '21: 11.8M Q1 '22: 14M Q2 '22: 744.1K Q3 '22: 744.5K Q1 '23: 744.5K Q2 '23: 75.7K Q3 '23: 92.4K Q1 '24: 194.2K Q2 '24: 949.7K Q3 '24: 2.1M Q1 '25: 3.8M Q2 '25: 453.6K Q3 '25: 577.2K Q1 '26: 8.5M Q2 '26: 950.8K Q3 '26: 1.6M Q1 '22 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-120.00 -80.00 -40.00 0.00 40.00 80.00 120.00 Q4 '20: -0.37 Q1 '21: -0.40 Q2 '21: -0.41 Q3 '21: -0.67 Q4 '21: -0.66 Q1 '22: -0.64 Q2 '23: -11.76 Q3 '23: -78.64 Q4 '23: -98.81 Q1 '24: -109.67 Q2 '24: -106.18 Q3 '24: -38.94 Q4 '25: -14.19 Q1 '26: -13.84 Q2 '26: -11.70 Q3 '26: -9.09 Q4 '26: -5.87 Q1 '21 Q4 '21 Q3 '23 Q2 '24 Q1 '26 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.